Epitranscriptomic Reader HNRNPA2B1 Confers Endocrine Resistance to Breast Cancer Cells

Despite new combination therapies improving survival of breast cancer patients with estrogen receptor α (ER+) tumors, the molecular mechanisms for endocrine-resistant metastatic disease remain unresolved. HNRNPA2B1 (Heterogeneous Nuclear Ribonucleoprotein A2/B1), an RNA binding protein that function...

Descripción completa

Detalles Bibliográficos
Autores principales: Klinge, Carolyn M, Petri, Belinda J, Piell, Kellianne M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Steroid Hormones and Receptors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090017/
http://dx.doi.org/10.1210/jendso/bvab048.1643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090017/
http://dx.doi.org/10.1210/jendso/bvab048.1643

Ejemplares similares